Skip to main content
Erschienen in: Annals of Surgical Oncology 2/2009

01.02.2009 | Gastrointestinal Oncology

Impact of Postoperative Infection on Long-Term Survival After Potentially Curative Resection for Gastric Cancer

verfasst von: Hironori Tsujimoto, MD, PhD, Takashi Ichikura, MD, PhD, Satoshi Ono, MD, PhD, Hidekazu Sugasawa, MD, Shuichi Hiraki, MD, Naoko Sakamoto, MD, Yoshihisa Yaguchi, MD, Kazumichi Yoshida, MD, Yusuke Matsumoto, MD, Kazuo Hase, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

We focused on the impact of postoperative infection on long-term survival after potentially curative resection for gastric cancer. Postoperative surgical and medical complications have been implicated as a negative predictor of long-term outcome in various malignancies. However, there have been no published reports assessing the impact of complications arising from postoperative infection on survival in gastric cancer. We studied a population of 1,332 patients who underwent curative resection for gastric cancer. These patients were divided into two groups based on the occurrence (141 patients, 10.6%) or absence (1,191 patients, 89.4%) of postoperative complications due to infection. We investigated the demographic and clinicopathological features of each patient with and without postoperative complications from infection, and thereby the impact of postoperative infection on long-term survival. Patients with postoperative infection had significantly higher frequency of males, upper side tumor location, and total gastrectomy as a surgical procedure, more advanced stage of gastric cancer, and greater age compared with those without postoperative infection. Patients with complications due to postoperative infection had significantly more unfavorable outcome compared with those patients without postoperative infection. Multivariate analysis demonstrated that age, preoperative comorbidity, blood transfusion, tumor depth, nodal involvement, and postoperative infection correlated with overall survival. We conclude that postoperative complications from infection are a predictor of adverse clinical outcome in patients with gastric cancer. However, further immunological study and prospective trials are necessary to confirm the biological significance of these findings.
Literatur
1.
Zurück zum Zitat Collins TC, Daley J, Henderson WH, Khuri SF. Risk factors for prolonged length of stay after major elective surgery. Ann Surg. 1999;230:251–9.PubMedCrossRef Collins TC, Daley J, Henderson WH, Khuri SF. Risk factors for prolonged length of stay after major elective surgery. Ann Surg. 1999;230:251–9.PubMedCrossRef
2.
Zurück zum Zitat Tsutsui S, Moriguchi S, Morita M, et al. Multivariate analysis of postoperative complications after esophageal resection. Ann Thorac Surg. 1992;53:1052–6.PubMedCrossRef Tsutsui S, Moriguchi S, Morita M, et al. Multivariate analysis of postoperative complications after esophageal resection. Ann Thorac Surg. 1992;53:1052–6.PubMedCrossRef
3.
4.
Zurück zum Zitat Nowacki MP, Szymendera JJ. The strongest prognostic factors in colorectal carcinoma. Surgicopathologic stage of disease and postoperative fever. Dis Colon Rectum. 1983;26:263–8.CrossRef Nowacki MP, Szymendera JJ. The strongest prognostic factors in colorectal carcinoma. Surgicopathologic stage of disease and postoperative fever. Dis Colon Rectum. 1983;26:263–8.CrossRef
5.
Zurück zum Zitat Hirai T, Yamashita Y, Mukaida H, Kuwahara M, Inoue H, Toge T. Poor prognosis in esophageal cancer patients with postoperative complications. Surg Today. 1998;28:576–9.PubMedCrossRef Hirai T, Yamashita Y, Mukaida H, Kuwahara M, Inoue H, Toge T. Poor prognosis in esophageal cancer patients with postoperative complications. Surg Today. 1998;28:576–9.PubMedCrossRef
6.
Zurück zum Zitat Lagarde SM, de Boer JD, ten Kate FJ, Busch OR, Obertop H, van Lanschot JJ. Postoperative complications after esophagectomy for adenocarcinoma of the esophagus are related to timing of death due to recurrence. Ann Surg. 2008;247:71–6.PubMedCrossRef Lagarde SM, de Boer JD, ten Kate FJ, Busch OR, Obertop H, van Lanschot JJ. Postoperative complications after esophagectomy for adenocarcinoma of the esophagus are related to timing of death due to recurrence. Ann Surg. 2008;247:71–6.PubMedCrossRef
7.
Zurück zum Zitat Fucini C, Bandettini L, D’Elia M, Filipponi F, Herd-Smith A. Are postoperative fever and/or septic complications prognostic factors in colorectal cancer resected for cure? Dis Colon Rectum. 1985;28:94–5.PubMedCrossRef Fucini C, Bandettini L, D’Elia M, Filipponi F, Herd-Smith A. Are postoperative fever and/or septic complications prognostic factors in colorectal cancer resected for cure? Dis Colon Rectum. 1985;28:94–5.PubMedCrossRef
8.
Zurück zum Zitat Akyol AM, McGregor JR, Galloway DJ, Murray GD, George WD. Anastomotic leaks in colorectal cancer surgery: a risk factor for recurrence? Int J Colorectal Dis. 1991;6:179–83.PubMedCrossRef Akyol AM, McGregor JR, Galloway DJ, Murray GD, George WD. Anastomotic leaks in colorectal cancer surgery: a risk factor for recurrence? Int J Colorectal Dis. 1991;6:179–83.PubMedCrossRef
9.
Zurück zum Zitat Nespoli A, Gianotti L, Totis M, Bovo G, Nespoli L, Chiodini P, et al. Correlation between postoperative infections and long-term survival after colorectal resection for cancer. Tumori. 2004;90:485–90.PubMed Nespoli A, Gianotti L, Totis M, Bovo G, Nespoli L, Chiodini P, et al. Correlation between postoperative infections and long-term survival after colorectal resection for cancer. Tumori. 2004;90:485–90.PubMed
10.
Zurück zum Zitat Sensenig DM, Rossi NP, Ehrenhaft JL. Results of the surgical treatment of bronchogenic carcinoma. Surg Gynecol Obstet. 1963;116:279–84.PubMed Sensenig DM, Rossi NP, Ehrenhaft JL. Results of the surgical treatment of bronchogenic carcinoma. Surg Gynecol Obstet. 1963;116:279–84.PubMed
11.
Zurück zum Zitat Ruckdeschel JC, Codish SD, Stranahan A, McKneally MF. Postoperative empyema improves survival in lung cancer. Documentation and analysis of a natural experiment. N Engl J Med. 1972;287:1013–7. Ruckdeschel JC, Codish SD, Stranahan A, McKneally MF. Postoperative empyema improves survival in lung cancer. Documentation and analysis of a natural experiment. N Engl J Med. 1972;287:1013–7.
12.
Zurück zum Zitat Dionigi R, Dominioni L, Campani M. Infections in cancer patients. Surg Clin North Am. 1980;60:145–59.PubMed Dionigi R, Dominioni L, Campani M. Infections in cancer patients. Surg Clin North Am. 1980;60:145–59.PubMed
13.
Zurück zum Zitat Wigmore SJ, McMahon AJ, Sturgeon CM, Fearon KC. Acute-phase protein response, survival and tumour recurrence in patients with colorectal cancer. Br J Surg. 2001;88:255–60.PubMedCrossRef Wigmore SJ, McMahon AJ, Sturgeon CM, Fearon KC. Acute-phase protein response, survival and tumour recurrence in patients with colorectal cancer. Br J Surg. 2001;88:255–60.PubMedCrossRef
14.
Zurück zum Zitat Varty PP, Linehan IP, Boulos PB. Intra-abdominal sepsis and survival after surgery for colorectal cancer. Br J Surg. 1994;81:915–8.PubMedCrossRef Varty PP, Linehan IP, Boulos PB. Intra-abdominal sepsis and survival after surgery for colorectal cancer. Br J Surg. 1994;81:915–8.PubMedCrossRef
15.
Zurück zum Zitat Sobin LH, Fleming ID. TNM Classification of Malignant Tumors. 5th ed (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer. 1997;80:1803–4. Sobin LH, Fleming ID. TNM Classification of Malignant Tumors. 5th ed (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer. 1997;80:1803–4.
16.
Zurück zum Zitat Walker KG, Bell SW, Rickard MJ, Mehanna D, Dent OF, Chapuis PH, et al. Anastomotic leakage is predictive of diminished survival after potentially curative resection for colorectal cancer. Ann Surg. 2004;240:255–9.PubMedCrossRef Walker KG, Bell SW, Rickard MJ, Mehanna D, Dent OF, Chapuis PH, et al. Anastomotic leakage is predictive of diminished survival after potentially curative resection for colorectal cancer. Ann Surg. 2004;240:255–9.PubMedCrossRef
17.
Zurück zum Zitat Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer. 2004;4:11–22.PubMedCrossRef Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer. 2004;4:11–22.PubMedCrossRef
18.
Zurück zum Zitat Perwez Hussain S, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer. 2007;121:2373–80.PubMedCrossRef Perwez Hussain S, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer. 2007;121:2373–80.PubMedCrossRef
19.
Zurück zum Zitat Smyth MJ, Cretney E, Kershaw MH, Hayakawa Y. Cytokines in cancer immunity and immunotherapy. Immunol Rev. 2004;202:275–93.PubMedCrossRef Smyth MJ, Cretney E, Kershaw MH, Hayakawa Y. Cytokines in cancer immunity and immunotherapy. Immunol Rev. 2004;202:275–93.PubMedCrossRef
20.
Zurück zum Zitat Majima T, Ichikura T, Chochi K, et al. Exploitation of interleukin–18 by gastric cancers for their growth and evasion of host immunity. Int J Cancer. 2006;118:388–95.PubMedCrossRef Majima T, Ichikura T, Chochi K, et al. Exploitation of interleukin–18 by gastric cancers for their growth and evasion of host immunity. Int J Cancer. 2006;118:388–95.PubMedCrossRef
21.
Zurück zum Zitat Sugasawa H, Ichikura T, Kinoshita M, et al. Gastric cancer cells exploit CD4 + cell-derived CCL5 for their growth and prevention of CD8 + cell-involved tumor elimination. Int J Cancer. 2008;122:2535–41.PubMedCrossRef Sugasawa H, Ichikura T, Kinoshita M, et al. Gastric cancer cells exploit CD4 + cell-derived CCL5 for their growth and prevention of CD8 + cell-involved tumor elimination. Int J Cancer. 2008;122:2535–41.PubMedCrossRef
22.
Zurück zum Zitat Chochi K, Ichikura T, Kinoshita M, et al. Helicobacter pylori augments growth of gastric cancers via the lipopolysaccharide-toll-like receptor 4 pathway whereas its lipopolysaccharide attenuates antitumor activities of human mononuclear cells. Clin Cancer Res. 2008;14:2909–17.PubMedCrossRef Chochi K, Ichikura T, Kinoshita M, et al. Helicobacter pylori augments growth of gastric cancers via the lipopolysaccharide-toll-like receptor 4 pathway whereas its lipopolysaccharide attenuates antitumor activities of human mononuclear cells. Clin Cancer Res. 2008;14:2909–17.PubMedCrossRef
23.
Zurück zum Zitat Khuri SF, Henderson WG, DePalma RG, Mosca C, Healey NA, Kumbhani DJ. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg. 2005;242:326–41.PubMed Khuri SF, Henderson WG, DePalma RG, Mosca C, Healey NA, Kumbhani DJ. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg. 2005;242:326–41.PubMed
24.
Zurück zum Zitat Aosasa S, Ono S, Mochizuki H, et al. Activation of monocytes and endothelial cells depends on the severity of surgical stress. World J Surg. 2000;24:10–16.PubMedCrossRef Aosasa S, Ono S, Mochizuki H, et al. Activation of monocytes and endothelial cells depends on the severity of surgical stress. World J Surg. 2000;24:10–16.PubMedCrossRef
25.
Zurück zum Zitat Mokart D, Capo C, Blache JL, Delpero JR, Houvenaeghel G, Martin C, et al. Early postoperative compensatory anti-inflammatory response syndrome is associated with septic complications after major surgical trauma in patients with cancer. Br J Surg. 2002;89:1450–6.PubMedCrossRef Mokart D, Capo C, Blache JL, Delpero JR, Houvenaeghel G, Martin C, et al. Early postoperative compensatory anti-inflammatory response syndrome is associated with septic complications after major surgical trauma in patients with cancer. Br J Surg. 2002;89:1450–6.PubMedCrossRef
26.
Zurück zum Zitat Tsujimoto H, Ono S, Majima T, et al. Differential toll-like receptor expression after ex vivo lipopolysaccharide exposure in patients with sepsis and following surgical stress. Clin Immunol. 2006;119:180–7.PubMedCrossRef Tsujimoto H, Ono S, Majima T, et al. Differential toll-like receptor expression after ex vivo lipopolysaccharide exposure in patients with sepsis and following surgical stress. Clin Immunol. 2006;119:180–7.PubMedCrossRef
27.
Zurück zum Zitat Ramer-Quinn DS, Baker RA, Sanders VM. Activated T helper 1 and T helper 2 cells differentially express the beta–2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production. J Immunol. 1997;159:4857–67.PubMed Ramer-Quinn DS, Baker RA, Sanders VM. Activated T helper 1 and T helper 2 cells differentially express the beta–2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production. J Immunol. 1997;159:4857–67.PubMed
28.
Zurück zum Zitat Spolarics Z, Siddiqi M, Siegel JH, Garcia ZC, Stein DS, Denny T, et al. Depressed interleukin–12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients. Crit Care Med. 2003;31:1722–9.PubMedCrossRef Spolarics Z, Siddiqi M, Siegel JH, Garcia ZC, Stein DS, Denny T, et al. Depressed interleukin–12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients. Crit Care Med. 2003;31:1722–9.PubMedCrossRef
29.
Zurück zum Zitat Clerici M, Shearer GM, Clerici E. Cytokine dysregulation in invasive cervical carcinoma and other human neoplasias: time to consider the TH1/TH2 paradigm. J Natl Cancer Inst. 1998;90:261–3.PubMedCrossRef Clerici M, Shearer GM, Clerici E. Cytokine dysregulation in invasive cervical carcinoma and other human neoplasias: time to consider the TH1/TH2 paradigm. J Natl Cancer Inst. 1998;90:261–3.PubMedCrossRef
30.
Zurück zum Zitat Moore KW, O’Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin–10. Annu Rev Immunol. 1993;11:165–90.PubMedCrossRef Moore KW, O’Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin–10. Annu Rev Immunol. 1993;11:165–90.PubMedCrossRef
31.
Zurück zum Zitat Beissert S, Hosoi J, Grabbe S, Asahina A, Granstein RD. IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. J Immunol. 1995;154:1280–6.PubMed Beissert S, Hosoi J, Grabbe S, Asahina A, Granstein RD. IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. J Immunol. 1995;154:1280–6.PubMed
32.
Zurück zum Zitat Majima T, Ichikura T, Seki S, Takayama E, Hiraide H, Mochizuki H. Interleukin-10 and interferon-gamma levels within the peritoneal cavity of patients with gastric cancer. J Surg Oncol. 2001;78:124–30.PubMedCrossRef Majima T, Ichikura T, Seki S, Takayama E, Hiraide H, Mochizuki H. Interleukin-10 and interferon-gamma levels within the peritoneal cavity of patients with gastric cancer. J Surg Oncol. 2001;78:124–30.PubMedCrossRef
33.
Zurück zum Zitat Majima T, Ichikura T, Seki S, et al. The influence of interleukin–10 and interleukin-18 on interferon-gamma production by peritoneal exudate cells in patients with gastric carcinoma. Anticancer Res. 2002;22:1193–9.PubMed Majima T, Ichikura T, Seki S, et al. The influence of interleukin–10 and interleukin-18 on interferon-gamma production by peritoneal exudate cells in patients with gastric carcinoma. Anticancer Res. 2002;22:1193–9.PubMed
34.
Zurück zum Zitat Mynster T, Christensen IJ, Moesgaard F, Nielsen HJ. Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer Danish RANX05 Colorectal Cancer Study Group. Br J Surg 2000;87:1553–62.PubMedCrossRef Mynster T, Christensen IJ, Moesgaard F, Nielsen HJ. Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer Danish RANX05 Colorectal Cancer Study Group. Br J Surg 2000;87:1553–62.PubMedCrossRef
Metadaten
Titel
Impact of Postoperative Infection on Long-Term Survival After Potentially Curative Resection for Gastric Cancer
verfasst von
Hironori Tsujimoto, MD, PhD
Takashi Ichikura, MD, PhD
Satoshi Ono, MD, PhD
Hidekazu Sugasawa, MD
Shuichi Hiraki, MD
Naoko Sakamoto, MD
Yoshihisa Yaguchi, MD
Kazumichi Yoshida, MD
Yusuke Matsumoto, MD
Kazuo Hase, MD, PhD
Publikationsdatum
01.02.2009
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 2/2009
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-008-0249-8

Weitere Artikel der Ausgabe 2/2009

Annals of Surgical Oncology 2/2009 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.